Abbvie Inc 's Revenue in the fiscal year 2025 $ 61,160.00 millions
Abbvie Inc 's Revenue in the fiscal year 2024 $ 56,334.00 millions
Abbvie Inc 's Revenue in the fiscal year 2023 $ 54,318.00 millions
Abbvie Inc 's Revenue in the fiscal year 2022 $ 58,054.00 millions
Abbvie Inc 's Revenue in the fiscal year 2021 $ 56,197.00 millions
ABBV Revenue second quarter 2026 Y/Y Growth Comment
Abbvie Inc achieved in the second quarter 2026, above Company average Revenue increase of 10.16% year on year, to $ 16,990.00 millions.
Looking into second quarter 2026 results within Major Pharmaceutical Preparations industry 102 other companies have achieved higher Revenue growth. While Abbvie Inc ' s Revenue growth of 10.16% ranks overall at the positon no. 1718 in the second quarter 2026.
Revenue by Quarter for the Fiscal Years 2023, 2024, 2025, 2026
Abbvie Inc 's Q/Q Revenue Growth
Revenue Q/Q Growth Statistics
High
Average
Low
23.76 %
2.07 %
-59.79 %
(Sep 30 2020)
ABBV's II. Quarter Q/Q Revenue Comment
Abbvie Inc achieved in the II. Quarter 2026 above company average sequential Revenue rise of 13.25%, to $ 16,990.00 millions, from $15,002.00 millions in the first quarter.
Within Major Pharmaceutical Preparations industry 52 other companies have achieved higher Revenue quarter on quarter growth. While Abbvie Inc 's Revenue growth quarter on quarter, overall rank is 698.
Abbvie Inc achieved in the II. Quarter 2026 above company average sequential Revenue rise of 13.25%, to $ 16,990.00 millions, from $15,002.00 millions in the first quarter.
Within Major Pharmaceutical Preparations industry 52 other companies have achieved higher Revenue quarter on quarter growth. While Abbvie Inc 's Revenue growth quarter on quarter, overall rank is 698.
Abbvie Inc 's 12 Months Revenue Growth Year on Year
Revenue TTM Growth
12 Months Ending (Jun 30 2026)
12 Months Ending (Mar 31 2026)
12 Months Ending (Dec 31 2025)
12 Months Ending (Sep 30 2025)
12 Months Ending (Jun 30 2025)
Cumulative Revenue 12 Months Ending
$ 64,386.00
$ 62,819.00
$ 61,160.00
$ 59,644.00
$ 58,328.00
Y / Y Revenue Growth (TTM)
10.39 %
9.5 %
8.57 %
7.4 %
6.05 %
Year on Year Revenue Growth Overall
Ranking
# 1943
# 1994
# 706
# 965
# 2221
Seqeuential Revenue Change (TTM)
2.49 %
2.71 %
2.54 %
2.26 %
1.68 %
Seq. Revenue Growth (TTM) Overall
Ranking
# 2460
# 2406
# 818
# 1993
# 1979
Cumulative Revenue growth Comment
Abbvie Inc saw improvement in Revenue growth trend, posting cumulative 12 months Revenue growth of 10.39% year on year, to $ 64,386 millions if the fiscal year would have ended in Jun 30 2026. Abbvie Inc 's trailing twelve months Revenue growth was higher than company's average 5.83% and higher than 9.5% growth in Mar 31 2026. But from twelve months ended Mar 31 2026 rise was beneth at 2.49 % from $62819 millions achieved in the period from Mar 31 2026 to Jun 30 2025. We witness drop-off happening, more obvious observing the usual Q/Q TTM historic rise that is stronger at5.83%. The momentum is even more impressive from twelve months ended Mar 31 2026 exhibited at 2.49 % increase from $62819 millions in the period from Mar 31 2026 to Jun 30 2025.
In the Healthcare sector 301 other companies have achieved higher trailing twelve month Revenue growth. While Total ranking has impoved so far to 1943, from total ranking in previous quarter at 1994.
Abbvie Inc saw improvement in Revenue growth trend, posting cumulative 12 months Revenue growth of 10.39% year on year, to $ 64,386 millions if the fiscal year would have ended in Jun 30 2026. Abbvie Inc 's trailing twelve months Revenue growth was higher than company's average 5.83% and higher than 9.5% growth in Mar 31 2026. But from twelve months ended Mar 31 2026 rise was beneth at 2.49 % from $62819 millions achieved in the period from Mar 31 2026 to Jun 30 2025. We witness drop-off happening, more obvious observing the usual Q/Q TTM historic rise that is stronger at5.83%. The momentum is even more impressive from twelve months ended Mar 31 2026 exhibited at 2.49 % increase from $62819 millions in the period from Mar 31 2026 to Jun 30 2025.
In the Healthcare sector 301 other companies have achieved higher trailing twelve month Revenue growth. While Total ranking has impoved so far to 1943, from total ranking in previous quarter at 1994.
About Abbvie Inc Revenue Growth Rates (ABBV), Current and Historic Growth - CSIMarket Analysis
How we calculate this
This page is based on issuer-reported fundamentals and CSIMarket’s U.S. equities database (20+ years).
Growth is computed using year-over-year (Y/Y), sequential, and trailing-twelve-month (TTM) methods.
Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com
Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.
17.46%